Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,788
Closed -$393K 108
2024
Q1
$393K Buy
8,788
+183
+2% +$7.55K 0.21% 69
2023
Q4
$341K Buy
8,605
+867
+11% +$31.1K 0.2% 71
2023
Q3
$278K Buy
7,738
+217
+3% +$7.7K 0.19% 71
2023
Q2
$261K Buy
7,521
+1,266
+20% +$45.4K 0.16% 83
2023
Q1
$223K Buy
+6,255
New +$219K 0.16% 81

Other funds holding GSK

FWG Holdings's GSK Position: Q2 2024 in Review

FWG Holdings sold out of GSK (GSK) in Q2 2024, closing a stake of 8,788 shares — an estimated $393K sold.

FWG Holdings first reported a position in GSK in Q1 2023 and held it in 5 quarters. The position peaked at $393K in Q1 2024. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • FWG Holdings reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • FWG Holdings sold 8,788 GSK shares in Q2 2024, an estimated $393K.
  • FWG Holdings first reported a position in GSK in Q1 2023 and held it in 5 quarters.
  • FWG Holdings's GSK position peaked at $393K in Q1 2024.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on FWG Holdings's 13F filing for Q2 2024, filed 31 Jul 2024.